G Yu Alekseevich

Regional Clinical Hospital, Krasnoyarsk, Russia.

4 publications 2017 – 2025 ORCID
RussiaStrokeIschemic StrokeFibrinolytic AgentsThrombolytic Therapy

What does G Yu Alekseevich research?

Dr. Alekseevich studies how well the medication Revelise (also known as alteplase) works for patients who have experienced ischemic strokes, which occur when a blood clot blocks blood flow to the brain. His research involves examining the results in everyday clinical settings rather than controlled environments, allowing for a better understanding of how the treatment performs across a diverse population, particularly among older patients and those with other health conditions who are at higher risk.

Key findings

  • In a study of 2,202 patients, 49.9% had good outcomes upon discharge after receiving Revelise for ischemic stroke.
  • After 90 days, the percentage of patients with good outcomes increased to 66.4%.
  • Revelise effectively reduces stroke-related disabilities even among older patients with various health issues.

Frequently asked questions

Does Dr. Alekseevich study ischemic stroke?
Yes, Dr. Alekseevich specializes in the treatment and outcomes of patients with ischemic stroke.
What medication has Dr. Alekseevich researched?
He has researched the medication Revelise (alteplase) and its effectiveness in treating ischemic stroke.
Is Dr. Alekseevich's work relevant for older patients?
Yes, his research specifically includes older patients and examines how they respond to treatment for ischemic stroke.

Publications in plain English

[Thrombolytic Therapy for Ischemic Stroke with Revelise: Results of a Two-Year Follow-Up in the International PRIMA Study].

2025

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Shamalov NA, Khasanova DR, Marchenko SV, Soldatov MA, Azarova AG +46 more

Plain English
This study looked at how well and safely Revelise (alteplase), a medication for treating ischemic stroke (IS), works in real-life situations. It involved 2,202 patients, mostly around 68 years old, and found that nearly half (49.9%) of them had good outcomes when discharged, rising to 66.4% after 90 days. The results showed that Revelise effectively reduces stroke-related disabilities, even in older patients and those with other health issues. Who this helps: This benefits patients who suffer from ischemic strokes and the doctors treating them.

PubMed

[Ischemic stroke at a young age on the context of chronic myeloleukosis].

2021

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Isaeva NV, Shnyakin PG, Alekseevich GY, Kuznetsov VY, Medvedeva MK

Plain English
This study looked at a young patient who suffered a serious ischemic stroke due to chronic myeloleukosis (a type of blood cancer). It found that failing to follow up on medical advice led to more severe complications during treatment. This matters because timely diagnosis and treatment are crucial to prevent strokes and other serious health issues in young patients. Who this helps: This helps patients with chronic myeloleukosis and their doctors.

PubMed

[The application of the Multi-Touch pad for the evaluation of the fine motor activity of the wrist].

2017

Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury

Alekseevich GV, Mozheiko EY, Prokopenko SV, Shul'min AV, Gavrilyuk OA +1 more

Plain English
This study looked at a new way to measure fine hand movements in patients who have difficulty with wrist movements after having a stroke. Researchers tested 42 patients and found that this new method, using a multi-touch pad, was very reliable, with a measurement consistency score of 0.98. The findings align closely with established assessment methods, suggesting this approach can be a useful tool in clinics for evaluating recovery in stroke patients. Who this helps: Patients recovering from a stroke and their doctors.

PubMed

[An analysis of postoperative cognitive dysfunction in different methods of coronary artery bypass].

2017

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Alekseevich GY, Rodikov MV, Marchenko AV, Myalyuk PA, Alekseevich GV

Plain English
This study looked at how coronary artery bypass surgery affects thinking and memory in patients with heart disease. The researchers followed 192 patients who had different types of surgery; they found that those who had the standard surgery were 3.2 times more likely to experience problems with thinking after the operation. In contrast, patients who had a different, tailored approach to surgery showed some signs of improvement in their cognitive abilities after the procedure, which is promising. Who this helps: This helps patients with coronary artery disease and their doctors.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.